Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.

NCT01994720 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01994720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01994720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Completed
Start date
January 7, 2014
Completion date
March 2, 2016
Enrollment
13,307 (actual)
Sites
521

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischaemic stroke, transient ischaemic attack